Search results for "SERUM"

showing 10 items of 786 documents

Azapropazone binding to human serum albumin

1980

Azapropazone, a new non-steroidal antiinflammatory drug, is strongly bound to human serum albumin. As revealed by Scatchard analysis, one high-affinity binding site with an association constant of about 1.2 x 10(6)M-1 and two low-affinity binding sites with association constants of about 0.05 x 10(6)M-1 were found. While the high-affinity binding site of azapropazone is clearly not identical with the diazepam or digitoxin binding sites of human serum albumin, contradictory evidence was found by optical measurements and displacement studies for the similarity of the azapropazone and the warfarin binding site of human serum albumin. At present, it is suggested that both drugs bind to differen…

ApazoneDigitoxinOptical measurementsEndogenyPlasma protein bindingIn Vitro TechniquesPharmacologyBinding CompetitivemedicineHumansBinding siteSerum AlbuminAzapropazonePharmacologyBinding SitesAntiinflammatory drugTriazinesChemistryCircular DichroismGeneral MedicineHuman serum albuminPhenylbutazoneBiochemistryDialysisProtein Bindingmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model.

2012

Background The blood-brain barrier (BBB) represents an insurmountable obstacle for most drugs thus obstructing an effective treatment of many brain diseases. One solution for overcoming this barrier is a transport by binding of these drugs to surface-modified nanoparticles. Especially apolipoprotein E (ApoE) appears to play a major role in the nanoparticle-mediated drug transport across the BBB. However, at present the underlying mechanism is incompletely understood. Methodology/Principal Findings In this study, the uptake of the ApoE-modified nanoparticles into the brain capillary endothelial cells was investigated to differentiate between active and passive uptake mechanism by flow cytome…

Apolipoprotein EDrugs and DevicesDrug Research and DevelopmentLipoproteinsMaterials Sciencelcsh:MedicinePlasma protein bindingBiologyBlood–brain barrierBiochemistryFlow cytometryApolipoproteins EMaterial by AttributeMiceApolipoproteins EDrug Delivery Systemsddc:570Cell Line TumormedicineAnimalsHumansNanotechnologyPharmacokineticsReceptorlcsh:ScienceBiologySerum AlbuminBrain DiseasesMultidisciplinaryMicroscopy Confocalmedicine.diagnostic_testlcsh:RBrainEndothelial CellsProteinsBiological TransportFlow CytometryCell biologymedicine.anatomical_structureBlood-Brain BarrierNanoparticles for drug delivery to the brainLDL receptorNanoparticlesMedicinelcsh:QProtein BindingResearch ArticleBiotechnologyPLoS ONE
researchProduct

Serum pentraxin 3 as a clinical biomarker of branch atheromatous disease: a marker of brain ischaemia or an atherotrombosis marker?

2020

Atheromatous diseasePathologymedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryBiomarkerBrain IschemiaClinical biomarkerSerum Amyloid P-ComponentC-Reactive ProteinNeurologyIschaemic strokemedicineHumansNeurology (clinical)businessBiomarkersHumanPentraxin-3European journal of neurologyReferences
researchProduct

Generic Method for Modular Surface Modification of Cellulosic Materials in Aqueous Medium by Sequential Click-Reaction and Adsorption

2012

A generic approach for heterogeneous surface modification of cellulosic materials in aqueous medium, applicable for a wide range of functionalizations, is presented. In the first step, carboxymethyl cellulose (CMC) modified with azide or alkyne functionality, was adsorbed on a cellulosic substrate, thus, providing reactive sites for azide–alkyne cycloaddition click reactions. In the second step, functional units with complementary click units were reacted on the cellulose surface, coated by the click-modified CMC. Selected model functionalizations on diverse cellulosic substrates are shown to demonstrate the generality of the approach. The concept by sequentially combining the robust physic…

AzidesMagnetic Resonance SpectroscopyPolymers and PlasticsSurface Propertiesta221BioengineeringMicroscopy Atomic ForceCatalysisNanocellulosePolyethylene GlycolsmaterialsBiomaterialschemistry.chemical_compoundAdsorptionSpectroscopy Fourier Transform Infraredotorhinolaryngologic diseasesMaterials ChemistrymedicineOrganic chemistryAnimalsCotton FiberCelluloseta216ta116ta215ta218nanocelluloseFluorescent Dyesta214ta114Photoelectron Spectroscopyclick-reactionsSubstrate (chemistry)WaterSerum Albumin BovineCombinatorial chemistrycelluloseCarboxymethyl cellulosefunctionalchemistryadsorptionAlkynesCarboxymethylcellulose SodiumSurface functionalizationClick chemistrySurface modificationCattleAzidemedicine.drugBIOMACROMOLECULES
researchProduct

Choosing the Right Antifungal Agent in ICU Patients

2019

Fungi are responsible for around 20% of microbiologically documented infections in intensive care units (ICU). In the last decade, the incidence of invasive fungal infections (IFI), including candidemia, has increased steadily because of increased numbers of both immunocompromised and ICU patients. To improve the outcomes of patients with IFI, intensivists need to be aware of the inherent challenges. This narrative review summarizes the features of routinely used treatments directed against IFI in non-neutropenic ICU patients, which include three classes of antifungals: polyenes, azoles, and echinocandins. ICU patients' pathophysiological changes are responsible for deep changes in the phar…

AzolesAntifungal AgentsReviewKidney Function TestsInvasive aspergillosiEchinocandins0302 clinical medicineLiver Function Tests[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesMedicineDrug InteractionsPharmacology (medical)030212 general & internal medicineComputingMilieux_MISCELLANEOUSmedia_common[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases0303 health sciencesIncidenceIncidence (epidemiology)CandidiasisGeneral MedicineSerum concentrationIntensive care patients3. Good healthIntensive Care UnitsPractice Guidelines as Topic[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyCandidiasiNarrative reviewDrug MonitoringInvasive fungi infectionAntifungalDrugmedicine.medical_specialtyIcu patientsmedicine.drug_classmedia_common.quotation_subjectPharmacokineticPolyenesImmunocompromised Host03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemIntensive careHumansPharmacokinetics[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologyIntensive care medicineIntensive care patient030306 microbiologybusiness.industry[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyInvasive aspergillosisLiver functionbusinessPractical guidelinesInvasive Fungal InfectionsAdvances in Therapy
researchProduct

Deregulation of miR-324/KISS1/kisspeptin in early ectopic pregnancy: mechanistic findings with clinical and diagnostic implications

2019

[Abstract] BACKGROUND: Ectopic pregnancy is a life-threatening condition for which novel screening tools that would enable early accurate diagnosis would improve clinical outcomes. Kisspeptins, encoded by KISS1, play an essential role in human reproduction, at least partially by regulating placental function and possibly embryo implantation. Kisspeptin levels are elevated massively in normal pregnancy and reportedly altered in various gestational pathologic diseases. Yet, the pathophysiologic role of KISS1/kisspeptin in ectopic pregnancy has not been investigated previously. OBJECTIVE: The purpose of this study was to evaluate changes of KISS1/kisspeptin levels in ectopic pregnancy and thei…

BIOMARKERdiagnosisEctopic pregnancyPlacentaUNKNOWN LOCATIONPhysiology0302 clinical medicineKisspeptinPregnancyDiagnosis030212 general & internal medicineKisspeptins030219 obstetrics & reproductive medicineEctopic pregnancyObstetrics & GynecologyObstetrics and GynecologyPregnancy Ectopicmedicine.anatomical_structureectopic pregnancyBiomarker (medicine)GestationFemaleKISSPEPTINLife Sciences & BiomedicineSERUM PROGESTERONEhormones hormone substitutes and hormone antagonistsmiR-324-3pEXPRESSIONDown-RegulationGestational AgeReal-Time Polymerase Chain ReactionVALIDATION03 medical and health sciencesKisspeptinsPlacentamicroRNAmedicineHumansMESSENGER-RNASRNA MessengerObstetrics & Reproductive MedicinePregnancyScience & Technologybusiness.industryDecision TreesKISS 1BiomarkerEmbryo Mammalianmedicine.diseaseMicroRNAsEarly DiagnosisCase-Control Studies1114 Paediatrics and Reproductive MedicineKISS1businessBiomarkers
researchProduct

�ber die Bedeutung der Plasmaproteinbindung f�r Verteilung und Wirkung von Tranquillantien vom Benzodiazepintyp

1977

This paper discusses the problem if the plasma protein binding of benzodiazepine derivatives can influence distribution and pharmacological activity of the drugs. The distribution of the benzodiazepines in the organism is influenced not only by the plasma protein binding of the drugs, but also by several other factors, especially since the drugs are mostly lipophilic. Thus, an effect of the plasma protein binding on the distribution can only be expected if the benzodiazepine derivative is highly bound to the plasma proteins. Thus results have been shown only for diazepam and chlordiazepoxid, which indicate an effect of the plasma protein binding on distribution and pharmacological activity,…

Benzodiazepinebiologymedicine.drug_classChemistrySerum albuminAlbuminBiological activityGeneral MedicinePlasma protein bindingPharmacologyBlood proteinsIn vivoDrug Discoverymedicinebiology.proteinMolecular MedicineDistribution (pharmacology)Genetics (clinical)Klinische Wochenschrift
researchProduct

Aggregation Behavior of Polystyrene-Nanoparticles in Human Blood Serum and its Impact on the in vivo Distribution in Mice

2014

The interactions between nanoparticles (NPs) and proteins in complex biological application media such as blood serum are capable of inducing aggregate formation which can lead to subsequent changes in biological activity. Here, we correlate surface charge, aggregation-tendency, and surface serum protein adsorption with cellular uptake and biodistribution in mice. Polystyrene-based NPs (80 - 170 nm) with different surface functionalizations were synthesized and incubated with human serum. Interaction of NPs with serum proteins and aggregate formation were analyzed by mass spectrometryanalysis and dynamic light-scattering. Influence of surface functionalization on specific cellular uptake an…

BiodistributionMaterials scienceeducationtechnology industry and agricultureBiomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)NanoparticleBioengineeringProtein CoronaNanotechnologyBlood proteinsBlood serumIn vivoBiophysicsSurface modificationSurface chargeJournal of Nanomedicine & Nanotechnology
researchProduct

Unraveling the In Vivo Protein Corona

2021

Understanding the behavior of nanoparticles upon contact with a physiological environment is of urgent need in order to improve their properties for a successful therapeutic application. Most commonly, the interaction of nanoparticles with plasma proteins are studied under in vitro conditions. However, this has been shown to not reflect the complex situation after in vivo administration. Therefore, here we focused on the investigation of magnetic nanoparticles with blood proteins under in vivo conditions. Importantly, we observed a radically different proteome in vivo in comparison to the in vitro situation underlining the significance of in vivo protein corona studies. Next to this, we fou…

BiodistributionProtein CoronaCell Communication02 engineering and technology010402 general chemistry01 natural sciencesArticleMiceprotein coronaIn vivoAnimalsTissue DistributionMagnetite Nanoparticleslcsh:QH301-705.5biodistributionplasmaWhole bloodChemistrynanoparticleGeneral Medicine021001 nanoscience & nanotechnologyBlood proteinsIn vitro0104 chemical sciencesMice Inbred C57BLin vivoRAW 264.7 Cellslcsh:Biology (General)ProteomeBiophysics0210 nano-technologyserumEx vivoCells
researchProduct

Effect of endothelial cell heterogeneity on nanoparticle uptake.

2020

Endothelial cells exhibit distinct properties in morphology and functions in different organs that can be exploited for nanomedicine targeting. In this work, endothelial cells from different organs, i.e. brain, lung, liver, and kidney, were exposed to plain, carboxylated, and amino-modified silica. As expected, different protein coronas were formed on the different nanoparticle types and these changed when foetal bovine serum (FBS) or human serum were used. Uptake efficiencies differed strongly in the different endothelia, confirming that the cells retained some of their organ-specific differences. However, all endothelia showed higher uptake for the amino-modified silica in FBS, but, inter…

Biodistributionmedia_common.quotation_subjectReceptor expressionEndothelial cellsBristol Heart InstitutePharmaceutical ScienceUptake02 engineering and technologyADHESIONBlood–brain barrier030226 pharmacology & pharmacySERUM03 medical and health sciencesDELIVERY0302 clinical medicineBIODISTRIBUTIONmedicineHumansBovine serum albuminInternalization/dk/atira/pure/core/keywords/heart_SRImedia_commonchemistry.chemical_classificationKidneyPROTEIN-CORONAbiologyChemistryBLOOD-BRAIN-BARRIEREndothelial CellsBiological Transportrespiratory system021001 nanoscience & nanotechnologyCell biologyEndothelial stem cellSURFACE-CHARGEmedicine.anatomical_structureSIZENanomedicineTransferrinProtein coronabiology.proteinINTERNALIZATIONNanoparticlesProtein CoronaHeterogeneityMEMBRANE0210 nano-technologyEndothelial cell targetingInternational journal of pharmaceutics
researchProduct